SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036179
Filing Date
2020-08-05
Accepted
2020-08-04 17:34:28
Documents
74
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q flgt-10q_20200630.htm 10-Q 2259166
2 EX-31.1 flgt-ex311_6.htm EX-31.1 19158
3 EX-31.2 flgt-ex312_7.htm EX-31.2 18830
4 EX-32.1 flgt-ex321_8.htm EX-32.1 18179
  Complete submission text file 0001564590-20-036179.txt   7550249

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT flgt-20200630.xml EX-101.INS 1736918
6 XBRL TAXONOMY EXTENSION SCHEMA flgt-20200630.xsd EX-101.SCH 49688
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flgt-20200630_cal.xml EX-101.CAL 53241
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flgt-20200630_def.xml EX-101.DEF 131551
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE flgt-20200630_lab.xml EX-101.LAB 369978
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flgt-20200630_pre.xml EX-101.PRE 280113
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37894 | Film No.: 201074425
SIC: 8071 Services-Medical Laboratories